Oral immunotherapy (OIT) induces clinical tolerance in peanut-allergic children

被引:0
|
作者
Varshney, P. [1 ]
Jones, S. M. [2 ]
Pons, L. [1 ]
Kulis, M. [1 ]
Steele, P. H. [1 ]
Kemper, A. R. [1 ]
Scurlock, A. M. [2 ]
Perry, T. T. [2 ]
Burks, A. W. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Little Rock, AR 72205 USA
来源
CLINICAL AND EXPERIMENTAL ALLERGY | 2009年 / 39卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1956 / 1957
页数:2
相关论文
共 50 条
  • [21] Clinical Desensitization of Peanut Allergic Children Using Peanut Oral Immunotherapy
    Hofmann, Alison
    Steele, Pamela
    Kamilaris, Janet
    Scurlock, Amy
    Jones, Stacie
    Burks, A.
    CLINICAL IMMUNOLOGY, 2009, 131 : S59 - S59
  • [22] Sustained Unresponsiveness After Sublingual Immunotherapy for Peanut-allergic Children
    Yang, Luanna
    Steele, Pamela H.
    Hamilton, Deanna
    Bennick, Sarah
    Herlihy, Lauren
    Pitkin, Elizabeth
    Burks, A. Wesley
    Kim, Edwin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB175 - AB175
  • [23] A comparison of the outcome of nasal and oral peanut challenges in peanut-allergic children
    Clark, A.
    Mangat, J.
    Fletcher, J.
    King, Y.
    Islam, S.
    Anagnostou, K.
    Deighton, J.
    Ewan, P.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (12): : 1953 - 1953
  • [24] Safety of peanut oral immunotherapy (OIT)
    Hofmann, A. M.
    Steele, P.
    Kamilaris, S. M.
    Jones, S. M.
    Palmer, K. P.
    Perry, T. T.
    Scurlock, A. M.
    Althage, K. A.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S137 - S137
  • [25] Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results
    Pongracic, Jacqueline A.
    Gagnon, Remi
    Sussman, Gordon
    Siri, Dareen
    Oriel, Roxanne C.
    Brown-Whitehorn, Terri F.
    Green, Todd D.
    Campbell, Dianne E.
    Anvari, Sara
    Berger, William E.
    Bird, J. Andrew
    Chan, Edmond S.
    Cheema, Amarjit
    Chinthrajah, R. Sharon
    Chong, Hey Jin
    Dowling, Paul J.
    Fineman, Stanley M.
    Fleischer, David M.
    Gonzalez-Reyes, Erika
    Kim, Edwin H.
    Lanser, Bruce J.
    MacGinnitie, Andrew
    Mehta, Hemalini
    Petroni, Daniel
    Rupp, Ned
    Schneider, Lynda C.
    Scurlock, Amy M.
    Sher, Lawrence D.
    Shreffler, Wayne G.
    Sindher, Sayantani B.
    Stillerman, Allan
    Wood, Robert
    Yang, William H.
    Bois, Timothee
    Sampson, Hugh A.
    Begin, Philippe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1864 - +
  • [26] The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial
    Yu, G. P.
    Weldon, B.
    Neale-May, S.
    Nadeau, K. C.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2012, 159 (02) : 179 - 182
  • [27] Clinical characteristics of peanut-allergic children: Recent changes
    Todd, D. Green
    LaBelle, Virginia S.
    Steele, Pamela H.
    Kim, Edwin H.
    Lee, Laurie A.
    Mankad, Vaishali S.
    Williams, Larry W.
    Anstrom, Kevin J.
    Burks, A. Wesley
    PEDIATRICS, 2007, 120 (06) : 1304 - 1310
  • [28] Safety and efficacy of peanut sublingual immunotherapy in toddler-aged peanut-allergic children
    Kim, Edwin
    Bird, J. Andrew
    Herlihy, Lauren
    Arneson, Amy
    Hamilton, Deanna
    Ye, Ping
    Kulis, Michael
    Burks, A. Wesley
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB235 - AB235
  • [29] Epicutaneous Immunotherapy vs Placebo for Peanut Protein Ingestion Among Peanut-Allergic Children
    Zylke, Jody W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (10): : 956 - 956
  • [30] Immunoglobulin Changes using Different Dosing Regimens of Peanut Oral Immunotherapy (OIT) in Peanut Allergic Subjects
    Thyagarajan, A.
    Jones, S. M.
    Pons, L.
    Kulis, M.
    Smith, P. B.
    Steele, P. H.
    Kamilaris, J.
    Scurlock, A. M.
    Perry, T. T.
    Vickery, B.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB21 - AB21